Home › Ewing Sarcoma › Ohio
Pag-aaral pangklinika para sa Ewing Sarcoma sa Ohio
8 pag-aaral para sa Ewing Sarcoma ang naghahanap ng mga kalahok sa mga site sa Ohio.
Mga Lungsod sa Ohio
Opisyal na teksto ng pag-aaral (English)
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- Cleveland Clinic Children's, Cleveland
- Nationwide Children's Hospital, Columbus
Nagre-recruitPhase 1
Edad 1 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07194044Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitPhase 1
Edad 12 hanggang 85 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT03715933Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitPhase 1/2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT05210374Single Arm Romiplostim to Prevent CIT
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitMaagang Phase 1
Edad 1 pataas · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT07048249A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
- The Ohio State University Wexner Medical Center, Columbus
Nagre-recruit
Edad 13 pataas · Lahat ng kasarian · Na-update Peb 6, 2026 · NCT06387485Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
Nagre-recruitPhase 1/2
Edad 2 hanggang 30 · Lahat ng kasarian · Na-update Peb 3, 2026 · NCT05734066A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Nationwide Children's Hospital, Columbus
Nagre-recruitPhase 2
18 Months – 40 Years · Lahat ng kasarian · Na-update Ago 12, 2025 · NCT05135975Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.